Oxidized DNA induces an adaptive response in human fibroblasts

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 747-748, Issue , 2013, Pages 6-18

  Kostyuk, Svetlana V ^a   Tabakov, Viacheslav J ^a   Chestkov, Valerij V ^a   Konkova, Marina S ^a   Glebova, Kristina V ^a   Baydakova, Galina V ^a   Ershova, Elizaveta S ^a   Izhevskaya, Vera L ^a   Baranova, Ancha ^a,b   Veiko, Natalia N ^a  

^a RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

8 Oxo deoxyguanosine; Adaptive response; Cell free DNA; Low dose irradiation; Oxidized DNA; Serum starving

Indexed keywords

CYCLINE; DNA; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; OXIDIZED DNA; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

AIM2 GENE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL POPULATION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DNA MODIFICATION; DOUBLE STRANDED DNA BREAK; EMBRYO; FIBROBLAST CULTURE; GENE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN GENE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOLL LIKE RECEPTOR 9 GENE; TRANSCRIPTION FACTOR NRF2 GENE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CATTLE; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; CHROMATIN; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; CYTOKINES; DEOXYGUANOSINE; DNA; DNA DAMAGE; DNA METHYLATION; FIBROBLASTS; HUMANS; KI-67 ANTIGEN; LUNG; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SKIN; TOLL-LIKE RECEPTOR 9;

EID: 84879071406     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2013.04.007     Document Type: Article

References (68)

1. Ermakov A.V., Kostyuk S.V., Konkova M.S., Egolina N.A., Malinovskaya E.M., Veiko N.N. Extracellular DNA fragments: factors of stress signaling between X-irradiated and nonirradiated human lymphocytes. Ann. N. Y. Acad. Sci. 2008, 1137:41-46.
2. Ermakov A.V., Konkova M.S., Kostyuk S.V., Egolina N.A., Efremova L.V., Veiko N.N. Oxidative stress as a significant factor for development of an adaptive response in irradiated and nonirradiated human lymphocytes after inducing the bystander effect by low-dose X-radiation. Mutat. Res. 2009, 669:155-161.
3. Ermakov A.V., Konkova M.S., Kostyuk S.V., Smirnova T.D., Malinovskaya E.M., Efremova L.V., Veiko N.N. An extracellular DNA mediated bystander effect produced from low dose irradiated endothelial cells. Mutat. Res. 2011, 712:1-10.
4. Kostyuk S.V., Ermakov A.V., Alekseeva A.Y., Smirnova T.D., Glebova K.V., Baranova A., Veiko N.N. Role of extracellular DNA oxidative modification in radiation induced bystander effects in human endotheliocytes. Mutat. Res. 2012, 729:52-60.
5. Ermakov A.V., Kostiuk S.V., Egolina N.A., Malinovskaia E.M., Veǐko N.N., Spitkovskiǐ D.M. The DNA fragments obtained from the culture media exposed to adaptive doses of the ionizing radiation as factors of stress signaling between lymphocytes and bystander cells. Radiats. Biol. Radioecol. 2007, 47:133-140.
6. Cadet J., Ravanat J.L., TavernaPorro M., Menoni H., Angelov D. Oxidatively generated complex DNA damage: tandem and clustered lesions. Cancer Lett. 2012, 327:5-15.
7. Cadet J., Loft S., Olinski R., Evans M.D., Bialkowski K., Richard Wagner J., Dedon P.C., Møller P., Greenberg M.M., Cooke M.S. Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res. 2012, 46:367-381.
8. Loseva P., Kostyuk S., Malinovskaya E., Clement N., Dechesne C.A., Dani C., Smirnova T., Glebova K., Baidakova G., Baranova A., Izhevskaia V., Ginter E., Veiko N. Extracellular DNA oxidation stimulates activation of NRF2 and reduces the production of ROS in human mesenchymal stem cells. Expert Opin. Biol. Ther. 2012, 12:S85-S97.
9. Hartmann G., Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 2000, 164:944-952.
10. Yoshida H., Nishikawa M., Kiyota T., Toyota H., Takakura Y. Increase in CpG DNA-induced inflammatory responses by DNA oxidation in macrophages and mice. Free Radic. Biol. Med. 2011, 51:424-431.
11. Ohtsubo T., Ohya Y., Nakamura Y., Kansui Y., Furuichi M., Iida M., Nakabeppu Y. Accumulation of 8-oxo-deoxyguanosine in cardiovascular tissues with the development of hypertension. DNA Repair (Amst) 2007, 6:760-769.
12. Barja G., Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J. 2000, 14:312-318.
13. Roszkowski K., Jozwicki W., Blaszczyk P., Mucha-Malecka A., Siomek A. Oxidative damage DNA: 8-oxoGua and 8-oxodG as molecular markers of cancer. Med. Sci. Monit. 2011, 17:CR329-CR333.
14. Lagadu S., Lechevrel M., Sichel F., Breton J., Pottier D., Couderc R., Moussa F.V. Prevost, 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker of oxidative damage in oesophageal cancer patients: lack of association with antioxidant vitamins and polymorphism of hOGG1 and GST. J. Exp. Clin. Cancer Res. 2010, 29:157.
15. Hajizadeh S., DeGroot J., TeKoppele J.M., Tarkowski A., Collins L.V. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res. Ther. 2003, 5:R234-R240.
16. Collins L.V., Hajizadeh S., Holme E., Jonsson I.M., Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J. Leukoc. Biol. 2004, 75:995-1000.
17. Cooke M.S., Herbert K.E., Butler P.C., Lunec J. Further evidence for a possible role of conformation in the immunogenicity and antigenicity of the oxidative DNA lesion, 8-oxo-2'deoxyguanosine. Free Radic. Res. 1998, 28:459-469.
18. Philipp A.B., Stieber P., Nagel D., Neumann J., Spelsberg F., Jung A., Lamerz R., Herbst A., Kolligs F.T. Prognostic role of methylated free circulating DNA in colorectal cancer. Int. J. Cancer 2012, 131:2308-2319.
19. Zhai R., Zhao Y., Su L., Cassidy L., Liu G., Christiani D.C. Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia 2012, 14:29-33.
20. Morozkin E.S., Loseva E.M., Morozov I.V., Kurilshikov A.M., Bondar A.A., Rykova E.Y., Rubtsov N.B., Vlassov V.V., Laktionov P.P. A comparative study of cell-free apoptotic and genomic DNA using FISH and massive parallel sequencing. Expert Opin. Biol. Ther. 2012, (Suppl. 1):S11-S17.
21. Podcherniaeva R.Ia., Baklanova O.V., Glushchenko L.A., Isaeva E.I., Chestkov V.V.V., Tabakov Iu., Mikhaǐlova G.R. Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium. Vopr. Virusol. 2010, 55:47-49.
22. Singh R., Farmer P.B. Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. Carcinogenesis 2006, 27:178-196.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
24. Gannushkina I.V., Konorova I.L. Cell-free plasmic DNA as a blood factor determining hemodynamics in health and in vascular pathology. Patol. Fiziol. Eksp. Ter. 2008, July-September:2-10.
25. Guillaud P., du Manoir S., Seigneurin D. Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7). Anal. Cell Pathol. 1989, 11:25-39.
26. Naryzhny S.N. Proliferating cell nuclear antigen: a proteomics view. Cell Mol. Life Sci. 2008, 65:3789-3808.
27. Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., Barton O., Jeggo P.A. gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle 2010, 9:662-669.
28. Forman H.J., Maiorino M., Ursini F. Signaling functions of reactive oxygen species. Biochemistry 2010, 49:835-842.
29. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 1992, 5:227-231.
30. Gloire G., Legrand-Poels S., Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006, 72:1493-1505.
31. Hayden M.S., Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
32. Wang D A.S. Baldwin, Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 1998, 273:29411-29416.
33. Hayden M.S., Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012, 26:203-234.
34. Rahman A., Fazal F. Blocking NF-κB: an inflammatory issue. Proc. Am. Thorac. Soc. 2011, 8:497-503.
35. Nguyen T., Sherratt P.J., Nioi P., Yang C.S., Pickett C.B. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 2005, 280:32485-32492.
36. Dreger H., Westphal K., Weller A., Baumann G., Stangl V., Meiners S., Stangl K. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection. Cardiovasc. Res. 2009, 83:54-61.
37. Bauer S., Kirschning C.J., Häcker H., Redecke V., Hausmann S., Akira S., Wagner H., Lipford G.B. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9237-9242.
38. Huang X., Yang Y. Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses. Expert Opin. Ther. Targets 2010, 14:787-796.
39. Konkova M.S., Ermakov A.V., Efremova L.V., Kostyuk S.V., Veiko N.N. Influence of X-ray and/or CpG-DNA induced oxidative stress on adaptive response in human lymphocytes. Int. J. Low Radiat. 2010, 7:446-452.
40. Choubey D. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin. Immunol. 2012, 142:223-231.
41. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signaling. Nature 2008, 455:674-678.
42. Barber G.N. Cytoplasmic DNA innate immune pathways. Immunol. Rev. 2011, 243:99-108.
43. Deckbar D., Jeggo P.A., Löbrich M. Understanding the limitations of radiation-induced cell cycle checkpoints. Crit. Rev. Biochem. Mol. Biol. 2011, 46:271-283.
44. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
45. Pedruzzi L.M., Stockler-Pinto M.B., Leite M., Mafra D. Nrf2-keap1 system versus NF-κB: the good and the evil in chronic kidney disease?. Biochimie 2012, 94:2461-2466.
46. Wakabayashi N., Slocum S.L., Skoko J.J., Shin S., Kensler T.W. When NRF2 talks, who's listening?. Antioxid. Redox Signal. 2010, 13:1649-1663.
47. Ravanat J.L., Douki T., Duez P., Gremaud E., Herbert K., Hofer T., Lasserre L., Saint-Pierre C., Favier A., Cadet J. Cellular background level of 8-oxo-7 8-dihydro-2'-deoxyguanosine: an isotope based method to evaluate artefactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis 2002, 23:1911-1918.
48. Lagadu S., Lechevrel M., Sichel F., Breton J., Pottier D., Couderc R., Moussa F.V. Prevost, 8-oxo-7,8-dihydro-2'-deoxyguanosine as a biomarker of oxidative damage in oesophageal cancer patients: lack of association with antioxidant vitamins and polymorphism of hOGG1 and GST. J. Exp. Clin. Cancer Res. 2010, 29:157.
49. Szaflarska-Poplawska A., Siomek A., Czerwionka-Szaflarska M., Gackowski D., Rózalski R., Guz J., Szpila A., Zarakowska E., Olinski R. Oxidatively damaged DNA/oxidative stress in children with celiac disease. Cancer Epidemiol. Biomarkers Prev. 2010, 19:1960-1965.
50. Oli R.G., Fazeli G., Kuhn W., Walitza S., Gerlach M., Stopper H. No increased chromosomal damage in L-DOPA-treated patients with Parkinson's disease: a pilot study. J. Neural Transm. 2010, 117:737-746.
51. Dziaman T., Huzarski T., Gackowski D., Rozalski R., Siomek A., Szpila A., Guz J., Lubinski J., Wasowicz W., Roszkowski K., Olinski R. Selenium supplementation reduced oxidative DNA damage in adnexectomized BRCA1 mutations carriers. Cancer Epidemiol. Biomarkers Prev. 2009, 18:2923-2928.
52. Guz J., Foksinski M., Siomek A., Gackowski D., Rozalski R., Dziaman T., Szpila A., Olinski R. The relationship between 8-oxo-7 8-dihydro-2'-deoxyguanosine level and extent of cytosine methylation in leukocytes DNA of healthy subjects and in patients with colon adenomas and carcinomas. Mutat. Res. 2008, 640:170-173.
53. Matsui A., Ikeda T., Enomoto K., Hosoda K., Nakashima H., Omae K., Watanabe M., Hibi T., Kitajima M. Increased formation of oxidative DNA damage 8-hydroxy-2'-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 2000, 151:87-95.
54. Agbaje I.M., McVicar C.M., Schock B.C., McClure N., Atkinson A.B., Rogers D., Lewis S.E. Increased concentrations of the oxidative DNA adduct 7 8-dihydro-8-oxo-2-deoxyguanosine in the germ-line of men with type 1 diabetes. Reprod. Biomed. Online 2008, 16:401-409.
55. Al-Afaleg N.O., Al-Senaidy A., El-Ansary A. Oxidative stress and antioxidant status in Saudi asthmatic patients. Clin. Biochem. 2011, 44:612-617.
56. Siomek A., Gackowski D., Rozalski R., Dziaman T., Szpila A., Guz J., Olinski R. Higher leukocyte 8-oxo-7,8-dihydro-2'-deoxyguanosine and lower plasma ascorbate in aging humans?. Antioxid. Redox Signal. 2007, 9:143-150.
57. Kaneko T., Tahara S., Matsuo M. Non-linear accumulation of 8-hydroxy-2'-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat. Res. 1996, 316:277-285.
58. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., Pierotti M.A., Tavecchio L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 2001, 61:4675-4678.
59. Jahr S., Hentze H., Englisch S., Hardt D., Fackelmayer F.O., Hesch R.D., Knippers R. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001, 61:1659-1665.
60. Fleischhacker M., Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim. Biophys. Acta 2007, 1775:181-232.
61. Jylhävä J., Jylhä M., Lehtimäki T., Hervonen A., Hurme M. Circulating cell-free DNA is associated with mortality and inflammatory markers in nonagenarians: the Vitality 90+ Study. Exp. Gerontol. 2012, 47:372-378.
62. Atamaniuk J., Vidotto C., Kinzlbauer M., Bachl N., Tiran B., Tschan H. Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise. Eur. J. Appl. Physiol. 2010, 110:695-701.
63. Hahn S., Rusterholz C., Hösli I., Lapaire O. Cell-free nucleic acids as potential markers for preeclampsia. Placenta 2011, 32(Suppl):S17-S20.
64. Konorova I.L., Veiko N.N. Emotional stress in rats changes concentration and composition of extracellular DNA circulating in blood plasma under normal conditions and in cerebral ischemia. Bull. Exp. Biol. Med. 2012, 153:305-308.
65. Moore J.O., Palep S.R., Saladi R.N., Gao D., Wang Y., Phelps R.G., Lebwohl M.G., Wei H. Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin. Photochem. Photobiol. 2004, 80:587-595.
66. Shivji K.K., Kenny M.K., Wood R.D. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992, 69:367-374.
67. Shueng P.W., Lin S.C., Chang H.T., Chong N.S., Chen Y.J., Wang L.Y., Hsieh Y.P., Hsieh C.H. Toxicity risk of non-target organs at risk receiving low-dose radiation: case report. Radiat. Oncol. 2009, 4:71.
68. Takaya M., Niibe Y., Tsunoda S., Jobo T., Imai M., Kotani S., Unno N., Hayakawa K. Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma-a case report. Anticancer Res. 2007, 27:499-503.